Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
101
0
0.0
(
0
)
Added by
Xiang Wan
Publication date
2014
fields
Mathematical Statistics
and research's language is
English
Ask ChatGPT about the research
No Arabic abstract
In systematic reviews and meta-analysis, researchers often pool the results of the sample mean and standard deviation from a set of similar clinical trials. A number of the trials, however, reported the study using the median, the minimum and maximum values, and/or the first and third quartiles. Hence, in order to combine results, one may have to estimate the sample mean and standard deviation for such trials. In this paper, we propose to improve the existing literature in several directions. First, we show that the sample standard deviation estimation in Hozo et al. (2005) has some serious limitations and is always less satisfactory in practice. Inspired by this, we propose a new estimation method by incorporating the sample size. Second, we systematically study the sample mean and standard deviation estimation problem under more general settings where the first and third quartiles are also available for the trials. Through simulation studies, we demonstrate that the proposed methods greatly improve the existing methods and enrich the literature. We conclude our work with a summary table that serves as a comprehensive guidance for performing meta-analysis in different situations.
rate research
Read More
The era of big data is coming, and evidence-based medicine is attracting increasing attention to improve decision making in medical practice via integrating evidence from well designed and conducted clinical research. Meta-analysis is a statistical technique widely used in evidence-based medicine for analytically combining the findings from independent clinical trials to provide an overall estimation of a treatment effectiveness. The sample mean and standard deviation are two commonly used statistics in meta-analysis but some trials use the median, the minimum and maximum values, or sometimes the first and third quartiles to report the results. Thus, to pool results in a consistent format, researchers need to transform those information back to the sample mean and standard deviation. In this paper, we investigate the optimal estimation of the sample mean for meta-analysis from both theoretical and empirical perspectives. A major drawback in the literature is that the sample size, needless to say its importance, is either ignored or used in a stepwise but somewhat arbitrary manner, e.g., the famous method proposed by Hozo et al. We solve this issue by incorporating the sample size in a smoothly changing weight in the estimators to reach the optimal estimation. Our proposed estimators not only improve the existing ones significantly but also share the same virtue of the simplicity. The real data application indicates that our proposed estimators are capable to serve as rules of thumb and will be widely applied in evidence-based medicine.
When reporting the results of clinical studies, some researchers may choose the five-number summary (including the sample median, the first and third quartiles, and the minimum and maximum values) rather than the sample mean and standard deviation, particularly for skewed data. For these studies, when included in a meta-analysis, it is often desired to convert the five-number summary back to the sample mean and standard deviation. For this purpose, several methods have been proposed in the recent literature and they are increasingly used nowadays. In this paper, we propose to further advance the literature by developing a smoothly weighted estimator for the sample standard deviation that fully utilizes the sample size information. For ease of implementation, we also derive an approximation formula for the optimal weight, as well as a shortcut formula for the sample standard deviation. Numerical results show that our new estimator provides a more accurate estimate for normal data and also performs favorably for non-normal data. Together with the optimal sample mean estimator in Luo et al., our new methods have dramatically improved the existing methods for data transformation, and they are capable to serve as rules of thumb in meta-analysis for studies reported with the five-number summary. Finally for practical use, an Excel spreadsheet and an online calculator are also provided for implementing our optimal estimators.
In some clinical studies, researchers may report the five number summary (including the sample median, the first and third quartiles, and the minimum and maximum values) rather than the sample mean and standard deviation. To conduct meta-analysis for pooling studies, one needs to first estimate the sample mean and standard deviation from the five number summary. A number of studies have been proposed in the recent literature to solve this problem. However, none of the existing estimators for the standard deviation is satisfactory for practical use. After a brief review of the existing literature, we point out that Wan et al.s method (BMC Med Res Methodol 14:135, 2014) has a serious limitation in estimating the standard deviation from the five number summary. To improve it, we propose a smoothly weighted estimator by incorporating the sample size information and derive the optimal weight for the new estimator. For ease of implementation, we also provide an approximation formula of the optimal weight and a shortcut formula for estimating the standard deviation from the five number summary. The performance of the proposed estimator is evaluated through two simulation studies. In comparison with Wan et al.s estimator, our new estimator provides a more accurate estimate for normal data and performs favorably for non-normal data. In real data analysis, our new method is also able to provide a more accurate estimate of the true sample standard deviation than the existing method. In this paper, we propose an optimal estimator of the standard deviation from the five number summary. Together with the optimal mean estimator in Luo et al. (Stat Methods Med Res, in press, 2017), our new methods have improved the existing literature and will make a solid contribution to meta-analysis and evidence-based medicine.
For clinical studies with continuous outcomes, when the data are potentially skewed, researchers may choose to report the whole or part of the five-number summary (the sample median, the first and third quartiles, and the minimum and maximum values), rather than the sample mean and standard deviation. For the studies with skewed data, if we include them in the classical meta-analysis for normal data, it may yield misleading or even wrong conclusions. In this paper, we develop a flow chart and three new tests for detecting the skewness of data from the sample size and the five-number summary. Simulation studies demonstrate that our new tests are able to control the type I error rates, and meanwhile provide good statistical power. A real data example is also analyzed to demonstrate the usefulness of the skewness tests in meta-analysis and evidence-based practice.
Sequential Multiple Assignment Randomized Trials (SMARTs) are considered the gold standard for estimation and evaluation of treatment regimes. SMARTs are typically sized to ensure sufficient power for a simple comparison, e.g., the comparison of two fixed treatment sequences. Estimation of an optimal treatment regime is conducted as part of a secondary and hypothesis-generating analysis with formal evaluation of the estimated optimal regime deferred to a follow-up trial. However, running a follow-up trial to evaluate an estimated optimal treatment regime is costly and time-consuming; furthermore, the estimated optimal regime that is to be evaluated in such a follow-up trial may be far from optimal if the original trial was underpowered for estimation of an optimal regime. We derive sample size procedures for a SMART that ensure: (i) sufficient power for comparing the optimal treatment regime with standard of care; and (ii) the estimated optimal regime is within a given tolerance of the true optimal regime with high-probability. We establish asymptotic validity of the proposed procedures and demonstrate their finite sample performance in a series of simulation experiments.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
